ARTA
ATRA icon

A.R.T. Advisors’s Atara Biotherapeutics ATRA Stock Holding History

A.R.T. Advisors’s Portfolio ATRA Stock Details ATRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-2,185
Closed -$900K – 121
2019
Q4 		$900K Sell
2,185
-1,348
-38% -$465K 0.04% 605
2019
Q3 		$1.25M Buy
3,533
+1,756
+99% +$655K 0.06% 447
2019
Q2 		$893K Buy
1,777
+1,536
+637% +$1.08M 0.05% 503
2019
Q1 		$239K Buy
+241
New +$224K 0.01% 1027
2017
Q3 		– Sell
-738
Closed -$258K – 1347
2017
Q2 		$258K Buy
+738
New +$284K 0.01% 1066
2016
Q2 		– Sell
-2,558
Closed -$1.22M – 1350
2016
Q1 		$1.22M Buy
2,558
+1,134
+80% +$510K 0.05% 502
2015
Q4 		$940K Buy
+1,424
New +$1.08M 0.04% 588
2015
Q2 		– Sell
-505
Closed -$524K – 1474
2015
Q1 		$524K Buy
+505
New +$334K 0.02% 893

Other funds holding ATRA

BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
BM
Bridger Management New York $128M AUM 9.54% 1-Year Est. Return